Cantor Initiates Coverage of FWDI and CYPH with Overweight Rating
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Digital Asset Shift: Analysts highlight that a significant shift in financial infrastructure is occurring on-chain, with digital assets poised to capture a growing share of payments, credit, trading, and asset issuance, underscoring their importance in the future financial ecosystem.
- Forward Industries Investment: Forward Industries acquired over 500,000 Solana (SOL) tokens at an average price of approximately $79 during Q3 of fiscal 2026, indicating a proactive stance towards digital assets that is expected to enhance its balance sheet yield potential.
- Price Target Setting: Cantor has set a price target of $7.90 for Forward Industries and $0.90 for Cypherpunk Technologies, reflecting optimistic market expectations regarding the growth potential of both companies.
- Rating Discrepancies: Forward Industries is rated as Hold by Seeking Alpha's Quant Ratings system, yet receives a Strong Buy rating from Wall Street analysts, illustrating a divergence in market sentiment regarding its future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CYPH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CYPH
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cantor Initiates Coverage of FWDI and CYPH with Overweight Rating
- Digital Asset Shift: Analysts highlight that a significant shift in financial infrastructure is occurring on-chain, with digital assets poised to capture a growing share of payments, credit, trading, and asset issuance, underscoring their importance in the future financial ecosystem.
- Forward Industries Investment: Forward Industries acquired over 500,000 Solana (SOL) tokens at an average price of approximately $79 during Q3 of fiscal 2026, indicating a proactive stance towards digital assets that is expected to enhance its balance sheet yield potential.
- Price Target Setting: Cantor has set a price target of $7.90 for Forward Industries and $0.90 for Cypherpunk Technologies, reflecting optimistic market expectations regarding the growth potential of both companies.
- Rating Discrepancies: Forward Industries is rated as Hold by Seeking Alpha's Quant Ratings system, yet receives a Strong Buy rating from Wall Street analysts, illustrating a divergence in market sentiment regarding its future performance.
See More
Latest Wall Street Rating Updates
- Abbott Labs Upgrade: Baird initiates coverage on Abbott Labs (ABT) with an outperform rating, projecting steady revenue and earnings growth of 6-8% over the next few years, bolstered by its leading position in the rapidly growing MedDevice market, enhancing the company's competitive edge.
- Murphy USA Upgrade: Jefferies upgrades Murphy USA (MUSA) from hold to buy, citing improving fuel margins that are expected to drive EBITDA outlook significantly higher by 20-25%, which will materially enhance the company's financial performance in the coming years.
- Abivax Upgrade: Jefferies raises Abivax (ABVX) to buy, noting strong data for its ulcerative colitis drug that alleviates key market concerns, which is likely to drive a rebound in the stock price.
- Talos Energy Upgrade: Roth upgrades Talos Energy (TALO) from neutral to buy, raising the price target by 6% to $17, based on its robust balance sheet and low production decline rates, indicating strong future growth potential.
See More
Cypherpunk Technologies Reports Q1 Earnings
- Earnings Report: Cypherpunk Technologies reported a Q1 GAAP EPS of -$0.46, indicating challenges in profitability that may affect investor confidence and market perception.
- Historical Financial Data: Historical earnings data shows a persistent decline in profitability for Cypherpunk Technologies, reflecting pressure in market competition that could complicate future financing efforts.
- Market Reaction: The ongoing losses have led to cautious market sentiment regarding Cypherpunk's outlook, potentially resulting in increased stock price volatility and impacting the company's ability to secure funding.
- Future Outlook: The company must implement effective strategies to improve its financial health to restore investor confidence and ensure long-term sustainability, particularly in the highly competitive tech sector.
See More
Cypherpunk Technologies Reports Q1 2026 Financial Results
- Widening Financial Losses: In Q1 2026, Cypherpunk reported a net loss of $77.2 million, significantly up from $15.4 million in Q1 2025, primarily due to unrealized losses on the fair value of ZEC holdings, highlighting the volatility in the digital asset market.
- Significant Reduction in R&D Expenses: The company spent only $0.2 million on R&D in Q1 2026, a drastic decrease from $12.9 million in the same period of 2025, mainly due to reduced clinical trial and manufacturing costs, indicating efforts to control expenditures.
- Deteriorating Cash Flow Position: As of March 31, 2026, Cypherpunk's cash and cash equivalents totaled $6.7 million, down from $14.0 million at the end of 2025, suggesting liquidity pressures that could impact future operations and investment capabilities.
- Strategic Investment Shift: The $5 million investment in Zcash Open Development Labs reflects Cypherpunk's commitment to supporting the Zcash ecosystem, indicating a long-term strategy in privacy technology despite current financial challenges.
See More
Cypherpunk Technologies Acquires New ZEC and Launches New Website
- New ZEC Acquisition: Cypherpunk Technologies Inc. purchased 9,163.32 ZEC for $2.15 million at an average price of $234.63 per ZEC, increasing its total holdings to 303,906.40 ZEC and enhancing its ownership stake in the Zcash network to 1.82%.
- Website and Investor Dashboard Launch: The newly launched website, cypherpunk.com, features a dedicated investor dashboard that provides transparency into key metrics, ZEC holdings, and other privacy investments, aiming to improve shareholder access to critical company information.
- Future Disclosure Channels: Cypherpunk announced that future ZEC acquisitions and company updates will be communicated through digital channels, marking a shift away from traditional press releases and enhancing direct communication with investors.
- Privacy Technology Mission: As a privacy technology company, Cypherpunk is focused on advancing internet privacy through Zcash accumulation and investments in frontier technologies, demonstrating its strategic positioning in the rapidly evolving digital asset market.
See More
Cypherpunk Technologies Acquires New ZEC and Launches New Website
- New ZEC Acquisition: Cypherpunk Technologies purchased 9,163.32 ZEC for $2,150,000 at an average price of $234.63 per ZEC, increasing its total holdings to 303,906.40 ZEC and elevating its ownership in the Zcash network to 1.82%, which may enhance its market position.
- Website and Investor Dashboard Launch: The newly launched website, cypherpunk.com, features a dedicated investor dashboard that provides transparency into key metrics, ZEC holdings, and privacy investments, aiming to strengthen investor trust and engagement with the company’s operations.
- Future Disclosure Channels: Cypherpunk has committed to announcing future ZEC acquisitions and company updates through its new website and social media channels, ensuring that investors receive timely information, which could improve communication efficiency and investor relations.
- Privacy Technology Mission: As a privacy technology company, Cypherpunk aims to advance privacy guarantees through Zcash accumulation and investments in frontier technologies, while also developing novel therapies for cancer patients, showcasing its strategic positioning in the privacy tech sector.
See More
Cantor Initiates Coverage of FWDI and CYPH with Overweight Rating
- Digital Asset Shift: Analysts highlight that a significant shift in financial infrastructure is occurring on-chain, with digital assets poised to capture a growing share of payments, credit, trading, and asset issuance, underscoring their importance in the future financial ecosystem.
- Forward Industries Investment: Forward Industries acquired over 500,000 Solana (SOL) tokens at an average price of approximately $79 during Q3 of fiscal 2026, indicating a proactive stance towards digital assets that is expected to enhance its balance sheet yield potential.
- Price Target Setting: Cantor has set a price target of $7.90 for Forward Industries and $0.90 for Cypherpunk Technologies, reflecting optimistic market expectations regarding the growth potential of both companies.
- Rating Discrepancies: Forward Industries is rated as Hold by Seeking Alpha's Quant Ratings system, yet receives a Strong Buy rating from Wall Street analysts, illustrating a divergence in market sentiment regarding its future performance.
See More
Latest Wall Street Rating Updates
- Abbott Labs Upgrade: Baird initiates coverage on Abbott Labs (ABT) with an outperform rating, projecting steady revenue and earnings growth of 6-8% over the next few years, bolstered by its leading position in the rapidly growing MedDevice market, enhancing the company's competitive edge.
- Murphy USA Upgrade: Jefferies upgrades Murphy USA (MUSA) from hold to buy, citing improving fuel margins that are expected to drive EBITDA outlook significantly higher by 20-25%, which will materially enhance the company's financial performance in the coming years.
- Abivax Upgrade: Jefferies raises Abivax (ABVX) to buy, noting strong data for its ulcerative colitis drug that alleviates key market concerns, which is likely to drive a rebound in the stock price.
- Talos Energy Upgrade: Roth upgrades Talos Energy (TALO) from neutral to buy, raising the price target by 6% to $17, based on its robust balance sheet and low production decline rates, indicating strong future growth potential.
See More
Cypherpunk Technologies Reports Q1 Earnings
- Earnings Report: Cypherpunk Technologies reported a Q1 GAAP EPS of -$0.46, indicating challenges in profitability that may affect investor confidence and market perception.
- Historical Financial Data: Historical earnings data shows a persistent decline in profitability for Cypherpunk Technologies, reflecting pressure in market competition that could complicate future financing efforts.
- Market Reaction: The ongoing losses have led to cautious market sentiment regarding Cypherpunk's outlook, potentially resulting in increased stock price volatility and impacting the company's ability to secure funding.
- Future Outlook: The company must implement effective strategies to improve its financial health to restore investor confidence and ensure long-term sustainability, particularly in the highly competitive tech sector.
See More
Cypherpunk Technologies Reports Q1 2026 Financial Results
- Widening Financial Losses: In Q1 2026, Cypherpunk reported a net loss of $77.2 million, significantly up from $15.4 million in Q1 2025, primarily due to unrealized losses on the fair value of ZEC holdings, highlighting the volatility in the digital asset market.
- Significant Reduction in R&D Expenses: The company spent only $0.2 million on R&D in Q1 2026, a drastic decrease from $12.9 million in the same period of 2025, mainly due to reduced clinical trial and manufacturing costs, indicating efforts to control expenditures.
- Deteriorating Cash Flow Position: As of March 31, 2026, Cypherpunk's cash and cash equivalents totaled $6.7 million, down from $14.0 million at the end of 2025, suggesting liquidity pressures that could impact future operations and investment capabilities.
- Strategic Investment Shift: The $5 million investment in Zcash Open Development Labs reflects Cypherpunk's commitment to supporting the Zcash ecosystem, indicating a long-term strategy in privacy technology despite current financial challenges.
See More
Cypherpunk Technologies Acquires New ZEC and Launches New Website
- New ZEC Acquisition: Cypherpunk Technologies Inc. purchased 9,163.32 ZEC for $2.15 million at an average price of $234.63 per ZEC, increasing its total holdings to 303,906.40 ZEC and enhancing its ownership stake in the Zcash network to 1.82%.
- Website and Investor Dashboard Launch: The newly launched website, cypherpunk.com, features a dedicated investor dashboard that provides transparency into key metrics, ZEC holdings, and other privacy investments, aiming to improve shareholder access to critical company information.
- Future Disclosure Channels: Cypherpunk announced that future ZEC acquisitions and company updates will be communicated through digital channels, marking a shift away from traditional press releases and enhancing direct communication with investors.
- Privacy Technology Mission: As a privacy technology company, Cypherpunk is focused on advancing internet privacy through Zcash accumulation and investments in frontier technologies, demonstrating its strategic positioning in the rapidly evolving digital asset market.
See More
Cypherpunk Technologies Acquires New ZEC and Launches New Website
- New ZEC Acquisition: Cypherpunk Technologies purchased 9,163.32 ZEC for $2,150,000 at an average price of $234.63 per ZEC, increasing its total holdings to 303,906.40 ZEC and elevating its ownership in the Zcash network to 1.82%, which may enhance its market position.
- Website and Investor Dashboard Launch: The newly launched website, cypherpunk.com, features a dedicated investor dashboard that provides transparency into key metrics, ZEC holdings, and privacy investments, aiming to strengthen investor trust and engagement with the company’s operations.
- Future Disclosure Channels: Cypherpunk has committed to announcing future ZEC acquisitions and company updates through its new website and social media channels, ensuring that investors receive timely information, which could improve communication efficiency and investor relations.
- Privacy Technology Mission: As a privacy technology company, Cypherpunk aims to advance privacy guarantees through Zcash accumulation and investments in frontier technologies, while also developing novel therapies for cancer patients, showcasing its strategic positioning in the privacy tech sector.
See More
